News | Breast Imaging | March 23, 2018

Average Breast Tumor Size Decreased Following Introduction of Screening

European researchers found tumor sizes increasing again since 2001, suggesting screening numbers may be declining again

Average Breast Tumor Size Decreased Following Introduction of Screening

March 23, 2018 — The average size of breast cancers at diagnosis decreased dramatically in the 1980s and 1990s following the introduction of screening, according to research presented at the 11th European Breast Cancer Conference, March 21-23 in Barcelona, Spain.

However, the new research also reveals a slight increase in the average size of breast tumors since 2001, perhaps as a result of a decrease in the number of women going for screening in the same period.

The researchers say it is not yet clear whether the recent increase in average tumor size will lead to more deaths from breast cancer in the coming years. But they point out that, in general, women with smaller tumors at diagnosis have a better chance of surviving the disease.

The research was carried out by Manon Jenkins, junior doctor, Louise Merker, surgical registrar, Nicholas Gallegos, consultant surgeon, and colleagues at Weston General Hospital in Bristol, U.K.

Jenkins said: "In general terms, small breast cancers have a better prognosis than larger ones. Screening aims to detect breast cancers before they are large enough for a woman to feel them. If that's the case then the number of large cancers among women who are offered screening should fall and mortality should also decline."

The study involved 386,454 women in the United States who were diagnosed with breast cancer between 1983 and 2014. Researchers categorized the women according to when they were diagnosed and their age at diagnosis. For each group they calculated the average tumor size, allowing them to see how this has changed in different age groups over the decades since screening was introduced.

The results show that average tumor size has decreased by 23 percent over the 32-year period, from 26mm to 20mm, but the trend was not consistent over the years and varied according to the women's ages.

When breast screening was introduced in the early 1980s the average size of breast cancers fell sharply. In women aged between 70 and 74, there was a decline in the average size of tumors of 27 percent but in women aged 85 and older, the decline was only 10 percent. Average tumor size in these older women, who are less likely to be screened, remains the highest.

From 2001 to 2014, researchers discovered an unexpected rise in average tumor size of between 3 percent (in the 75 to 79 age group) and 13 percent (in women aged 50 to 54 years).

Jenkins said: "Rates of breast cancer survival have been improving steadily thanks both to the introduction of screening and to improvements in treatments. What we don't know is which has played the biggest role in improving survival.

"This study suggests that by reducing tumor size, screening provides a platform from which breast cancer treatments might work more effectively.

"The recent increase in the average size of tumors may reflect a decline in rates of screening. If this is followed by a deterioration in breast cancer mortality rates it would strengthen the argument for screening programs to continue. On the other hand, if declining screening rates are not followed by a rise in breast cancer death rates, it probably signals that advances in treatment are the main reason for the improvement in breast cancer mortality."

The researchers hope to continue to study this group, comparing the stage of the women's tumors as well as looking in more detail at the elderly population.

Prof. Robert Mansel is chair of the 11th European Breast Cancer Conference and Emeritus Professor of Surgery at Cardiff University School of Medicine, U.K., and was not involved with the research. He said: "This study suggests there has been an overall decline in the average size of breast tumors since screening was introduced and we know that smaller tumors do lead to better prognosis.

"The research also shows that the decline has been less pronounced in older women and that, more recently, there has been a slight increase in average tumor size overall. Both of these are of concern, and we will need to continue to monitor breast screening programs and their impact on survival in women of all ages."

For more information: www.ecco-org.eu/ebcc

 

Related Content

LVivo EF Comparable to MRI, Contrast Echo in Assessing Ejection Fraction
News | Cardiovascular Ultrasound | June 19, 2019
DiA Imaging Analysis announced the presentation of two studies assessing the performance and accuracy of the company's...
New Data Demonstrates Safety Profile of GammaTile Therapy for Various Brain Tumors
News | Brachytherapy Systems | June 18, 2019
GT Medical Technologies Inc. announced the presentation of clinical data from a prospective study of GammaTile Therapy...
Black Men Less Likely to Adopt Active Surveillance for Low-Risk Prostate Cancer
News | Prostate Cancer | June 17, 2019
A new study reveals black men are less likely than white men to adopt an active surveillance strategy for their...
Warm Springs Health & Wellness Center Implements Digisonics Solution for OB Ultrasound
News | Ultrasound Women's Health | June 17, 2019
Warm Springs Health & Wellness Center in Warm Springs, Ore., has selected the Digisonics OB PACS (picture archiving...
Fujifilm Announces Nationwide Breast Health Campaign With Mobile Mammography Coach

At the center of the campaign, Fujifilm will be traveling around the U.S. with its "Aspire to Be Fearless" mobile mammography coach to provide educational opportunities for clinicians, raise awareness about the importance of screening and will be providing mammograms to the underserved population in key locations.

News | Mammography | June 14, 2019
Fujifilm Medical Systems U.S.A. Inc. announced a nationwide awareness campaign titled ‘Aspire to Be Fearless’ focused...
Ikonopedia Showcases Risk Assessment and Resolution Manager Tools at SIIM and AHRA
News | Mammography Reporting Software | June 13, 2019
Ikonopedia will showcase its suite of structured breast reporting and Mammography Quality Standards Act (MQSA)...
iCAD Introduces ProFound AI for 2D Mammography in Europe
News | Artificial Intelligence | June 13, 2019
iCAD Inc. announced the launch of ProFound AI for 2D Mammography in Europe. This software is the latest addition to...
Three Palm Software Releases WorkstationOne Version 1.8.8
Technology | Mammography Reporting Software | June 12, 2019
Three Palm Software announced the release of the 1.8.8 version of its breast imaging workstation, WorkstationOne. This...
Volpara Health Technologies to Acquire MRS Systems Inc.
News | Mammography Reporting Software | June 04, 2019
Volpara Health Technologies, Volpara Solutions' parent company, has signed a binding agreement to acquire U.S.-based...
AI Biomarker Demonstrates High Predictive Power for Lung Cancer Immunotherapy
News | Artificial Intelligence | May 31, 2019
Lunit announced an abstract presentation of its artificial intelligence (AI) precision medicine research portfolio at...